Table of Contents: CATIE TreatmentUpdate

Table of Contents: CATIE TreatmentUpdate - 1998

Community AIDS Treatment Information Exchage
Edited by: Sean Hosein

TreatmentUpdate 94: December - Vol. 10, No. 10: Nelfinavir first?; T-20 - a fusion drug, first of several to come; Viral load - how low is best?; Maintaining a low viral load with nevirapine?; Macrophages - promise and peril
TreatmentUpdate 93: November - Vol. 10, No. 9: d4T and food - no problem; Indinavir - study highlights importance of CD4+ counts over viral load; Infections despite therapy with protease inhibitors; Abacavir gets green light from FDA advisory board; A boost for the immune system; Two immune boosters against Hepatitis C
TreatmentUpdate 92: October - Vol. 10, No. 8: Fortovase - new, more powerful version of saquinavir; Efavirenz (Sustiva) - a potent drug in combination; Twice daily indinavir trial stopped; Efavirenz use may cause false positive result for marijuana; Efavirenz approved in the U.S.; Nevirapine receives green light from Health Protection Branch; Ritonavir associated with possible kidney dysfunction; Liver problems with TB medication and hepatitis C; Symptoms of TB may get worse with anti-HIV therapy
TreatmentUpdate 91: September - Vol. 10, No. 7: Adherence to PCP medications found to be low; Stopping CMV prophylaxis with HAART; Baicalin - Chinese herbal extract for HIV; Testosterone for weight loss; Tea-tree oil for oral fungal infections; Nelfinavir access in Canada; An American study of WF10 looks promising
TreatmentUpdate 90: August - Vol. 10, No. 6: Salvage therapy or rescue therapy: Hydrea (hydroxyurea); Nukes alone can greatly suppress viral load; Salvage with Nelfinavir doesn't always work; Overview; Once daily triple therapy?; Anti-HIV drugs and birth defects; ddI once daily with Hydrea; Nelfinavir twice daily?; Confused fat cells and body shape changes
TreatmentUpdate 89: July - Vol. 10, No. 5: Carnitine may boost T cell counts; PIT study produces more questions than answers; Essiac for cancer?; Azithro once a week for MAC; Donating antibodies as a treatment for HIV
TreatmentUpdate 88: June - Vol. 10, No. 4: Atragen for KS; A new immune booster-IM-862 for KS; Aspirin for herpes?; New side effect of 3TC reported; Impact of HAART on KS in France; Doctors discover possible link between protease inhibitors and heart problems; Panretin capsules and gel for KS; Lymphoma, KS and new cancers-impact of HAART; Clues to cancer; Cidofovir may prove effective against KS; IL-2: not for KS?; Oncaspar for lymphoma
TreatmentUpdate 87: May - Vol. 10, No. 3: Amphotericin B and azithromycin for aspergillosis?; Garlic extract for HIV?; Megace and testosterone levels; Vitamin E deficiency in early HIV infection; G-CSF (filgrastim) for preventing infections; Recovery from PML with cidofovir; Itraconazole solution for oral yeast infections
TreatmentUpdate 86: April - Vol. 10, No. 2: Protease inhibitors and body shape changes; Retrovirus Conference overview; Combinations of protease inhibitors; Indinavir, nelfinavir - twice a day?; New Drugs: amprenavir and abacavir; Vitamin supplements may delay AIDS
TreatmentUpdate 85: March - Vol. 10, No. 1: Acyclovir: no survival benefit seen in a large study; Combination therapy for hepatitis C; High-dose valaciclovir linked to problems; New drug, new hope; Vitamin E for Hepatitis B?
Copyright / Funding / How to reach CATIE

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,1999. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.

Table Of Contents